Novartis Ag (NVS) Gross Margin (2009 - 2026)
Novartis Ag's Gross Margin came in at 78.02% for Q2 2026, down 3.91 percentage points from 81.93% a year earlier but up 1.26 percentage points from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Gross Margin (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Novartis Ag reported Gross Margin of 77.37%, down 1.63 percentage points year-over-year; for FY2025, it was 78.81%, up 1.51 percentage points from FY2024.
- Gross Margin carries a five-year change of +7.34 percentage points (FY2020 to FY2025).
- Going back by year, Gross Margin was 77.30% in FY2024 (+2.06 pp), 75.24% in FY2023 (-0.29 pp), 75.53% in FY2022 (+0.17 pp) and 75.36% in FY2021 (+3.89 pp).
- The five-year range for quarterly Gross Margin is 71.49% (Q1 2022) to 81.93% (Q2 2025).
- Year-over-year, Gross Margin has declined for three consecutive quarters, with an average year-over-year change of +0.35 percentage points over the last eight quarters.
- The fastest year-over-year change in Gross Margin over five years came in Q2 2025 (a gain of 4.41 percentage points), and the weakest in Q2 2026 (a drop of 3.91 percentage points).
- Business Quant data shows NVS's Gross Margin at 76.76% (Q1 2026), 76.85% (Q4 2025) and 77.78% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 75.71% |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn | 84.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 78.02% |
| Mar 31, 2026 | 76.76% |
| Dec 31, 2025 | 76.85% |
| Sep 30, 2025 | 77.78% |
| Jun 30, 2025 | 81.93% |
| Mar 31, 2025 | 78.54% |
| Dec 31, 2024 | 77.81% |
| Sep 30, 2024 | 77.50% |
| Jun 30, 2024 | 77.52% |
| Mar 31, 2024 | 76.29% |
| Dec 31, 2023 | 76.63% |
| Sep 30, 2023 | 76.18% |
| Jun 30, 2023 | 73.47% |
| Mar 31, 2023 | 74.61% |
| Dec 31, 2022 | 74.93% |
| Sep 30, 2022 | 75.38% |
| Jun 30, 2022 | 73.03% |
| Mar 31, 2022 | 71.49% |
| Dec 31, 2021 | 72.16% |
| Sep 30, 2021 | 72.36% |
API Access
Novartis Ag Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();